Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X4IV
|
||||
| Former ID |
DIB006285
|
||||
| Drug Name |
PSD-508
|
||||
| Synonyms |
M-5003; Dysmenorrhea therapy (intravaginal), Metris/Plethora; Intravaginal NSAID (dysmenorrhea), Plethora Solutions/Metris
|
||||
| Indication | Dysmenorrhea [ICD9: 625.3; ICD10:N94.4-N94.6] | Discontinued in Phase 2 | [1] | ||
| Company |
Metris Therapeutics Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027456) | ||||
| REF 2 | CN patent application no. 104797935, A method for prognosis and treatment of cancer metastasis. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.